277 related articles for article (PubMed ID: 2783323)
21. Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples.
Kolb WP; Morrow PR; Tamerius JD
Complement Inflamm; 1989; 6(3):175-204. PubMed ID: 2472921
[TBL] [Abstract][Full Text] [Related]
22. Interaction of soluble C3 fragments with guinea pig lymphocytes. Comparison of effects of C3a, C3b, C3c, and C3d on lymphokine production and lymphocyte proliferation.
Koopman WJ; Sandberg AL; Wahl SM; Mergenhagen SE
J Immunol; 1976 Jul; 117(1):331-6. PubMed ID: 932430
[TBL] [Abstract][Full Text] [Related]
23. The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1.
Montz H; Koch KC; Zierz R; Götze O
Immunology; 1991 Nov; 74(3):373-9. PubMed ID: 1769685
[TBL] [Abstract][Full Text] [Related]
24. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
Perez HD; Hooper C; Volanakis J; Ueda A
J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of bacterial lipopolysaccharide induction of interleukin 1 synthesis and secretion by human monocytes.
Arend WP; Massoni RJ
Clin Exp Immunol; 1986 Jun; 64(3):656-64. PubMed ID: 3491698
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells.
Warner SJ; Auger KR; Libby P
J Immunol; 1987 Sep; 139(6):1911-7. PubMed ID: 3497983
[TBL] [Abstract][Full Text] [Related]
27. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
Doherty DE; Haslett C; Tonnesen MG; Henson PM
J Immunol; 1987 Mar; 138(6):1762-71. PubMed ID: 3819394
[TBL] [Abstract][Full Text] [Related]
28. Lipopolysaccharide and interleukin 1 inhibit interferon-gamma-induced Fc receptor expression on human monocytes.
Arend WP; Ammons JT; Kotzin BL
J Immunol; 1987 Sep; 139(6):1873-9. PubMed ID: 2957441
[TBL] [Abstract][Full Text] [Related]
29. Insoluble immune complexes are most effective at triggering IL-10 production in human monocytes and synergize with TLR ligands and C5a.
DiMartino SJ; Yuan W; Redecha P; Ivashkiv LB; Salmon JE
Clin Immunol; 2008 Apr; 127(1):56-65. PubMed ID: 18201931
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
31. Effect of histamine on monocyte complement production. II. Modulation of protein secretion, degradation and synthesis.
Lappin D; Moseley HL; Whaley K
Clin Exp Immunol; 1980 Dec; 42(3):515-22. PubMed ID: 7011615
[TBL] [Abstract][Full Text] [Related]
32. Activation of bovine monocytes and neutrophils by the Bb fragment of complement factor B: demonstration by the uptake of 3H-deoxyglucose.
Sethi MS; Tabel H; Misra V
Can J Vet Res; 1990 Jan; 54(1):106-12. PubMed ID: 2306658
[TBL] [Abstract][Full Text] [Related]
33. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages.
Pue CA; Mortensen RF; Marsh CB; Pope HA; Wewers MD
J Immunol; 1996 Feb; 156(4):1594-600. PubMed ID: 8568265
[TBL] [Abstract][Full Text] [Related]
34. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
Leddy JP; Simons RL; Douglas RG
J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
[TBL] [Abstract][Full Text] [Related]
35. Contribution of complement factors and reaction pathways to inflammation.
Bitter-Suermann D
Agents Actions Suppl; 1982; 11():159-78. PubMed ID: 6758550
[No Abstract] [Full Text] [Related]
36. Flow cytometric assay for phagocytosis of human monocytes mediated via Fc gamma-receptors and complement receptor CR1 (CD35).
Andoh A; Fujiyama Y; Kitoh K; Hodohara K; Bamba T; Hosoda S
Cytometry; 1991; 12(7):677-86. PubMed ID: 1838328
[TBL] [Abstract][Full Text] [Related]
37. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
38. [The relationship between complement C3 receptors (CR1, CR3) on polymorphonuclear leukocytes and complement fragments during hemodialysis].
Ueda M; Deguchi M; Takemura S; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):679-84. PubMed ID: 1749118
[TBL] [Abstract][Full Text] [Related]
39. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes.
Arend WP; Massoni RJ
Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557
[TBL] [Abstract][Full Text] [Related]
40. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
